-
1
-
-
77953413391
-
Quality by Design - Four Years and Three Myths Later
-
February
-
Snee RD. Quality by Design - Four Years and Three Myths Later. Pharm. Process. February 2009: 14-16. www.pharmpro.com/articles/2010/03/government-and- regulatory-Implementing-Quality-by-Design.
-
(2009)
Pharm. Process.
, pp. 14-16
-
-
Snee, R.D.1
-
2
-
-
79952673161
-
Building a Framework for Quality by Design
-
online, October
-
Snee RD. Building a Framework for Quality by Design. Pharm. Technol. online, October 2009, http://pharmtech.findpharma.com/pharmtech/ Special+Section%3a+Quality+by+Design/Building-a-Framework-for-Quality-by-Design/ ArticleStandard/Article/detail/632988?ref=25.
-
(2009)
Pharm. Technol.
-
-
Snee, R.D.1
-
3
-
-
78650406479
-
Robust Strategies for Improving Upstream Productivity
-
Snee RD. Robust Strategies for Improving Upstream Productivity. BioPharm Int. 23(6) 2010: S28-S33.
-
(2010)
BioPharm Int.
, vol.23
, Issue.6
-
-
Snee, R.D.1
-
6
-
-
79952675568
-
Time Value of Information in Design of Downstream Purification Processes - Getting the Right Data in the Right Amount at the Right Time
-
Lonardo A, Snee RD, and Qi B. Time Value of Information in Design of Downstream Purification Processes - Getting the Right Data in the Right Amount at the Right Time. BioPharm Intl. 23(3) 2010: 23-28.
-
(2010)
BioPharm Intl.
, vol.23
, Issue.3
, pp. 23-28
-
-
Lonardo, A.1
Snee, R.D.2
Qi, B.3
-
7
-
-
73849112077
-
Raising Your Batting Average: Remember the Importance of Strategy in Experimentation
-
December
-
Snee RD. Raising Your Batting Average: Remember the Importance of Strategy in Experimentation. Quality Progress December 2009: 64-68.
-
(2009)
Quality Progress
, pp. 64-68
-
-
Snee, R.D.1
-
8
-
-
39049178749
-
Optimization of Fermentation Conditions for P450 BM-3 Monooxygenase Production by Hybrid Design Methodology
-
Yan L, Le-he M. Optimization of Fermentation Conditions for P450 BM-3 Monooxygenase Production by Hybrid Design Methodology. J. Zhejian University Science B 8(1): 27-32.
-
J. Zhejian University Science B
, vol.8
, Issue.1
, pp. 27-32
-
-
Yan, L.1
Le-he, M.2
-
9
-
-
58149083703
-
Risk Management in Pharmaceutical Product Development: White Paper Prepared by the PhRMA Drug Product Technology Group
-
Hulbert MH, et al. Risk Management in Pharmaceutical Product Development: White Paper Prepared by the PhRMA Drug Product Technology Group. J. Pharm. Innovation 3, 2008: 227-248.
-
(2008)
J. Pharm. Innovation
, vol.3
, pp. 227-248
-
-
Hulbert, M.H.1
-
10
-
-
77950677448
-
Implications and Opportunities of Applying QbD Principles to Analytical Measurements
-
Schweitzer M, et al. Implications and Opportunities of Applying QbD Principles to Analytical Measurements. Pharm. Technol. 33 (2) 2010, 52-59
-
(2010)
Pharm. Technol.
, vol.33
, Issue.2
, pp. 52-59
-
-
Schweitzer, M.1
-
11
-
-
29544433143
-
-
Wiley-Interscience: New York, NY
-
Box GEP, Hunter JS, and Hunter WG. Statistics for Experimenters - Design, Innovation, and Discovery. Wiley-Interscience: New York, NY, 2005.
-
(2005)
Statistics for Experimenters - Design, Innovation, and Discovery
-
-
Box, G.E.P.1
Hunter, J.S.2
Hunter, W.G.3
-
13
-
-
0013409865
-
Computer-Aided Design of Experiments: Some Practical Experiences
-
Snee RD. Computer-Aided Design of Experiments: Some Practical Experiences. J. Quality Technol. 17(4) 1985; 222-236
-
(1985)
J. Quality Technol.
, vol.17
, Issue.4
, pp. 222-236
-
-
Snee, R.D.1
|